|
G-Con Pods solved one of the major challenges for this facility as separation of processes in a facility like this with multiple independent stakeholders was critical. The comprehensiveness of the Pods allows for operations to be well-contained, a must for proprietary and safety concerns. In addition to G-Con's founders being members of the design team, G-Con Pods are the central technology imbedded in this facility. This multi-stakeholder, multi-purpose facility is a flexible-by-design biomanufacturing facility owned by Texas A&M University. All pharmaceutical manufacturing will occur inside G-Con Pods. |
 
|
Project GreenVax
Construction and management of a custom-designed 145,000 square foot biotherapeutic production facility. GreenVax is a plant-based vaccine facility developed by the Texas Plant-Expressed Vaccine Consortium and funded by the Defense Advanced Research Projects Agency (DARPA). This facility went from raw concept to completion and production in 18 months. G-Con Pods were the enabling technology that allowed this aggressive timeline to be met as the facility and the Pods were constructed simultaneously. The completed Pods were then placed and made operational in the host facility in a matter of days.  
|
